HTG ACTIVITIES REPORT – JUNE QUARTER 2021
HIGHLIGHTS: • Acquisition of U.S. based software-as-a-service (SaaS) company SnapSupport Inc. • Successfully raised $7.6 million via a private Placement… Read more
Incannex Files Patent for IHL-42X for Obstructive Sleep Apnoea
Incannex (IHL) has this morning announced that it has filed an International Patent Application entitled “Methods for the treatment of… Read more
IHL : Incannex engages Procaps to develop and manufacture IHL-675A soft-gel capsules in preparation for clinical trials
CEO and Managing Director of Incannex Healthcare, Mr Joel Latham, said; “Procaps offers Incannex a complete supply chain solution for… Read more
HTG : Appointment of Non-Executive Director
Confirmation of Capital Structure – CHESS Depositary Interests on Issue
Nyrada’s NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction in Preclinical Study
Nyrada Inc have this morning announced encouraging results from an invivo study of their PCSK9i cholesterol inhibitor combined with Pfizer’s… Read more
Incannex to develop IHL-216A formulation for use in pivotal clinical trials required for product registration
Vectura is a state-of-the-art contract development and manufacturing organisation (CDMO) that specialises in the development and manufacture of inhaled drugs… Read more